Cancer Chemo-immunotherapy: Exploiting the Immunogenic Momentum of Cytotoxic Chemotherapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1067113

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We recently found that chemotherapy has beneficial effects on the immune response against cancer rather than ill effects. Here we want to exploit this positive effect by combining different chemotherapeutics with immune-stimulating treatments in laboratory models. These studies will result in a better understanding of how chemotherapy influences the immune system, and may also result in new combinations that improve the effectiveness of cancer therapy.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $917,490.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer chemotherapeutic agents | cancer immunotherapy | cancer therapy | immunotherapy | tumour immunology

Related Links